QCM
Qsemble Capital Management Portfolio holdings
AUM
$1.04B
1-Year Return
11.1%
This Quarter Return
+7.78%
1 Year Return
+11.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.04B
AUM Growth
+$102M
(+11%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
6.94%
Top 10 Holdings %
Top 10 Hldgs %
10.26%
Holding
626
New
208
Increased
103
Reduced
99
Closed
216
Top Buys
| 1 |
TJX Companies
TJX
|
+$10.6M |
| 2 |
Danaher
DHR
|
+$10.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$10.3M |
| 4 |
Take-Two Interactive
TTWO
|
+$10.2M |
| 5 |
Mastercard
MA
|
+$10M |
Top Sells
| 1 |
Interactive Brokers
IBKR
|
+$12.3M |
| 2 |
Walt Disney
DIS
|
+$10.7M |
| 3 |
Halliburton
HAL
|
+$10.5M |
| 4 |
Honeywell
HON
|
+$9.45M |
| 5 |
Meta Platforms (Facebook)
META
|
+$9.42M |
Sector Composition
| 1 | Technology | 17.69% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 14.88% |
| 4 | Consumer Discretionary | 14.56% |
| 5 | Healthcare | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Repligen
RGEN
$6.68B
| $481K | 0.05% |
+3,871
| New | +$481K |
|
327
Microchip Technology
MCHP
$34.9B
| $478K | 0.05% |
+6,791
| New | +$478K |
|
328
Maximus
MMS
$4.93B
| $472K | 0.05% |
+6,724
| New | +$472K |
|
329
Chord Energy
CHRD
$5.88B
| $459K | 0.04% |
4,735
-3,194
| -40% | -$309K |
|
330
Madrigal Pharmaceuticals
MDGL
$10B
| $458K | 0.04% |
+1,513
| New | +$458K |
|
331
Quantum Computing Inc
QUBT
$2.59B
| $451K | 0.04% |
+23,535
| New | +$451K |
|
332
United Therapeutics
UTHR
$18.3B
| $449K | 0.04% |
+1,563
| New | +$449K |
|
333
Lamb Weston
LW
$7.96B
| $444K | 0.04% |
8,556
+3,388
| +66% | +$176K |
|
334
Becton Dickinson
BDX
$54.6B
| $437K | 0.04% |
+2,539
| New | +$437K |
|
335
Globant
GLOB
$2.64B
| $430K | 0.04% |
+4,732
| New | +$430K |
|
336
Omnicom Group
OMC
$15.1B
| $428K | 0.04% |
5,952
-1,736
| -23% | -$125K |
|
337
Duke Energy
DUK
$93.6B
| $426K | 0.04% |
+3,607
| New | +$426K |
|
338
UGI
UGI
$7.36B
| $425K | 0.04% |
11,662
-13,904
| -54% | -$506K |
|
339
Curtiss-Wright
CW
$18.2B
| $424K | 0.04% |
+867
| New | +$424K |
|
340
Revvity
RVTY
$9.87B
| $423K | 0.04% |
+4,374
| New | +$423K |
|
341
Moderna
MRNA
$9.52B
| $417K | 0.04% |
+15,130
| New | +$417K |
|
342
Gen Digital
GEN
$18.1B
| $412K | 0.04% |
+14,007
| New | +$412K |
|
343
Alcoa
AA
$8.1B
| $409K | 0.04% |
+13,859
| New | +$409K |
|
344
TG Therapeutics
TGTX
$5.08B
| $403K | 0.04% |
11,187
-20,609
| -65% | -$742K |
|
345
Duolingo
DUOL
$12.5B
| $402K | 0.04% |
+981
| New | +$402K |
|
346
Incyte
INCY
$16.7B
| $393K | 0.04% |
5,767
-3,809
| -40% | -$259K |
|
347
Jazz Pharmaceuticals
JAZZ
$7.8B
| $387K | 0.04% |
3,651
+49
| +1% | +$5.2K |
|
348
Antero Midstream
AM
$8.74B
| $380K | 0.04% |
20,038
-23,643
| -54% | -$448K |
|
349
CRISPR Therapeutics
CRSP
$4.88B
| $369K | 0.04% |
+7,581
| New | +$369K |
|
350
Signet Jewelers
SIG
$3.72B
| $364K | 0.03% |
+4,581
| New | +$364K |
|